Spinal Tech

The global spinal fusion devices market is set to hit nearly $7.44 billion by 2022, based on an Allied Market Research report, according to MarketWatch.

Walnut Creek, Calif.-based Providence Medical Technology earned FDA clearance for its CAVUX Cervical Cage-L System and ALLY Facet Screws.

Dublin-based Medtronic and New Brunswick, N.J.-based DePuy Synthes lead the cervical and lumbar artificial disc market, according to iData Research.

San Diego-based NuVasive announced FDA clearance of its CoRoent Small Interbody System for up to four contiguous levels.  

Aliso Viejo, Calif.-based OrthAlign announced the completion of the 60,000th joint arthroplasty case using the medical device company's technology.

Here, Steven C. Anagnost, MD, weighs in on the business aspect of spine surgery, in particular, the spinal implant industry.

Boise, Idaho-based Burst Biologics will begin a study involving spinal fusion patients.

Plainsboro, N.J.-based Integra LifeSciences announced full commercial availability of its Cadence Total Ankle system.  

Implanet's revenue jumped last year, driven by the U.S. market growth.

InVivo Therapeutics enrolled another patient in its INSPIRE study of the Neuro-Spinal Scaffold for spinal cord injury patients.